Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • angiogenesis (1)
  • cancer (7)
  • cell (5)
  • cell movement (1)
  • COL4A1 (1)
  • COL6A3 (8)
  • Collagen (2)
  • colon cancer (1)
  • diagnosis (1)
  • dukes stage (2)
  • female (1)
  • fibroblast (5)
  • filamin (1)
  • gene (1)
  • humans (1)
  • male (1)
  • over (1)
  • patients (1)
  • plasma (1)
  • poor prognosis (1)
  • prognosis (3)
  • protein human (1)
  • rna (2)
  • spondin 2 (1)
  • status (1)
  • t stage (2)
  • western blots (1)
  • wound (1)
  • Sizes of these terms reflect their relevance to your search.

    Colorectal cancer (CRC) represents the third most common cancer in males and second in females worldwide. Here, we performed a quantitative 8-plex iTRAQ proteomics analysis of the secreted proteins from five colonic fibroblast cultures and three colon cancer epithelial cell lines. We identified 1114 proteins at 0% FDR, including 587 potential secreted proteins. We further recognized 116 fibroblast-enriched proteins which were significantly associated with cell movement, angiogenesis, proliferation and wound healing, and 44 epithelial cell-enriched proteins. By interrogation of Oncomine database, we found that 20 and 8 fibroblast-enriched proteins were up- and downregulated in CRC, respectively. Western blots confirmed the fibroblast-specific secretion of filamin C, COL6A3, COL4A1 and spondin-2. Upregulated mRNA and stroma expression of COL6A3 in CRC, which were revealed by Oncomine analyses and tissue-microarray-immunohistochemistry, indicated poor prognosis. COL6A3 expression was significantly associated with Dukes stage, T stage, stage, recurrence and smoking status. Circulating plasma COL6A3 in CRC patients was upregulated significantly comparing with healthy peoples. Receiver operating characteristic curve analysis revealed that COL6A3 has better predictive performance for CRC with an area under the curve of 0.885 and the best sensitivity/specificity of 92.9%/81.3%. Thus we demonstrated that COL6A3 was a potential diagnosis and prognosis marker of CRC.


    Jie Qiao, Cai-Yun Fang, Sun-Xia Chen, Xiao-Qing Wang, Shu-Jian Cui, Xiao-Hui Liu, Ying-Hua Jiang, Jie Wang, Yang Zhang, Peng-Yuan Yang, Feng Liu. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics. Oncotarget. 2015 Oct 6;6(30):29929-46

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 26338966

    View Full Text